Literature DB >> 23093730

Dramatic increase in cervical cancer registrations in young women in 2009 in England unlikely to be due to the new policy not to screen women aged 20-24.

Peter Sasieni1, Alejandra Castanon.   

Abstract

OBJECTIVE: To explore whether the 17% increase in cervical cancer in England in 2009 was due to the change in cervical screening policy.
METHODS: Trends in incidence of cervical cancer and of cervical intraepithelial neoplasia grade 3 (CIN3) were analysed for England, Wales and Scotland. Invasive cervical cancer data on 4079 cancers in women aged 20-39 diagnosed between April 2007 and August 2011 in England were analysed by single year of age.
RESULTS: In England there was a 38% (95% confidence intervals [CI] 18-62%) increase in cervical cancer incidence rates in women aged 25-29 in 2009 relative to 2008, and a 30% (11-51%) increase in women aged 35-39. Compared rates in 2010 are similar to those in 2008. The average increase between 2000 and 2010 in women aged 25-29 was no greater in England than in Scotland and Wales (relative risk 0.98, 95% CI 0.69-1.39). In England there has been a gradual increase in CIN3 (particularly for ages 25-29) since 2003, with a more dramatic increase in 2009, but a fall in 2010. Audit data showed an increase in cancers diagnosed at age 25 in 2009/2010 and 2010/2011 (P ≤ 0.0004). No increase was observed at age 26. For ages 27-29 an increase in cancer was observed for 2008/2009-2009/2010 when compared with 2007/2008-2010/2011 (P < 0.00001), but linear trends were not significant.
CONCLUSIONS: The increase in cervical cancer in England in 2009 cannot be attributed to the lack of screening of women aged 20-24, or to a general decrease in the coverage or quality of cervical screening.

Entities:  

Mesh:

Year:  2012        PMID: 23093730     DOI: 10.1258/jms.2012.012081

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  5 in total

1.  Characteristics and screening history of women diagnosed with cervical cancer aged 20-29 years.

Authors:  A Castanon; V M W Leung; R Landy; A W W Lim; P Sasieni
Journal:  Br J Cancer       Date:  2013-07-02       Impact factor: 7.640

2.  Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.

Authors:  Marc Arbyn; Sara B Smith; Sarah Temin; Farhana Sultana; Philip Castle
Journal:  BMJ       Date:  2018-12-05

3.  Cervical cancer in women under 30 years of age in Norway: a population-based cohort study.

Authors:  Brit Helene Gravdal; Stefan Lönnberg; Gry Baadstrand Skare; Gerhard Sulo; Tone Bjørge
Journal:  BMC Womens Health       Date:  2021-03-18       Impact factor: 2.809

4.  Retracted Article: RNA-sequencing identified miR-3681 as a negative regulator in the proliferation and migration of cervical cancer cells via the posttranscriptional suppression of HGFR.

Authors:  Fan Shi; Yingbing Zhang; Juan Wang; Jin Su; Zi Liu; Tao Wang
Journal:  RSC Adv       Date:  2019-07-18       Impact factor: 4.036

5.  Human Papillomavirus Self-Sampling for Primary Cervical Cancer Screening in Under-Screened Women in Hong Kong during the COVID-19 Pandemic.

Authors:  Siew-Fei Ngu; Lesley S K Lau; Justin Li; Grace C Y Wong; Annie N Y Cheung; Hextan Y S Ngan; Karen K L Chan
Journal:  Int J Environ Res Public Health       Date:  2022-02-24       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.